Tomorrow in Islamabad, the Pakistan–China B2B Investment Conference kicks off, bringing together over 450+ firms to forge the Sino-Pak Pharma Alliance. With the support of DRAP, BOI, and SIFC, this summit isn’t just about discussions—it is about immediate, project-driven results. Dedicated on-site regulatory desks will be active to instantly fast-track licensing and joint venture approvals, […]
Stronger together for a healthier tomorrow. Read More »
A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to safeguard public health: The Pakistan Pharmaceutical Manufacturers Association (PPMA) strongly welcomes these landmark regulatory milestones, standing united with DRAP in this definitive victory for national patient safety and pharmaceutical innovation.
DRAP Mandates 2D Barcodes & Syringe Upgrades Read More »
Under the newly announced Federal Budget 2026-27, the government has officially exempted customs duties on critical cancer-related Active Pharmaceutical Ingredients (APIs). This public health relief will significantly reduce manufacturing costs and make life-saving cancer treatments much more affordable across Pakistan.
Budget 2026-27: Customs Duty Removed on Cancer APIs Read More »
We are thrilled to announce a major milestone for the pharmaceutical industry! The Embassy of Pakistan in Beijing and CODA have successfully mobilized over 40 leading Chinese Biopharma, API, and Medical Device giants for the upcoming 6th Pakistan-China B2B Investment Conference in Karachi this July 17–18. This strategic collaboration aims to drive advanced technology transfers
Strengthening Pak-China Healthcare Ties Read More »
A massive milestone for international trade and the pharmaceutical sector! Pakistan and Egypt are officially locking in fast-track pharmaceutical certifications to completely eliminate regulatory delays. This strategic move is set to drastically accelerate bilateral medicine exports, expanding the reach of high-quality healthcare products across South Asia and Africa. By streamlining these processes, the Pakistan Pharmaceutical
Building the Pak-Egypt Health Corridor Read More »
Synflex Tablet Uses, Side Effects, Dosage, Price & Warnings in Pakistan Many people in Pakistan use painkillers without fully understanding how they work, what risks they carry, and when they should actually be avoided. One of the most searched pain relief medicines in Pakistan is Synflex Tablet. Whether someone is suffering from joint pain, back
Synflex Tablet Uses, Side Effects, Dosage, Price & Warnings in Pakistan Read More »
Heat Stroke & Sun Stroke: Symptoms, Causes, First Aid, Treatment & Recovery Guide Heat stroke and sun stroke are among the most dangerous heat-related medical emergencies during summer and extreme heat conditions. Every year, thousands of people worldwide suffer from severe heat illnesses due to rising temperatures, dehydration, heat waves, and prolonged sun exposure. In
Heat Stroke & Sun Stroke: Symptoms, Causes, First Aid, Treatment & Recovery Guide Read More »
EXCESS BODY HEAT (Garmi Zyada Hona): Complete Medical, Practical Understanding Excess Heat, Body Heat, Heat Stroke, Heat Wave & Hyperthermia, Treatment, Prevention, Heat Stroke Management 1. WHAT IS EXCESS BODY HEAT? Excess body heat refers to a condition where the human body is unable to maintain its normal internal temperature due to an imbalance between
Excess Body Heat (Garmi Zyada Hona): Causes, Symptoms, Heat Stroke & Treatment Guide Read More »
The PPMA celebrates the achievement of WHO Prequalification by DRAP and CDL Karachi. This global seal of approval validates Pakistan’s position as a reliable provider of high-quality pharmaceutical products. Bridging the gap between local excellence and global standards.
Integrity, Quality, and Global Recognition. Read More »
The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to highlight a major milestone for our national healthcare infrastructure. With 85% of medicines consumed in Pakistan now manufactured locally, we are significantly reducing our dependence on imports and securing our supply chain against global disruptions. This isn’t just a statistic; it’s a shield for our people,
Building a self-reliant future, one life-saving dose at a time. Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
